Author

Didier Baert 1

1 AZ Maria Middelares,Gent,Belgium

ACCEPTANCE OF SWITCH, PATIENT SATISFACTION AND ADVERSE EVENTS AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR SB5 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A REAL-LIFE SETTING

Thomas De Somer, Didier Baert, Mieke Deceuninck, Inge Huys, Veerle Mattens, An Sterckx, Erik Vanderstraeten, Jo Vandervoort, Nina Van Heddegem, Pieter Dewint, Nele Deprez, Stijn Vanden Branden

EVALUATION OF TROUGH LEVEL AND DISEASE ACTIVITY AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Nele Deprez, Mieke Deceuninck, Didier Baert, Thomas De Somer, Inge Huys, Veerle Mattens, An Sterckx, Stijn Vanden Branden, Erik Vanderstraeten, Nina Van Heddegem, Pieter Dewint, Jo Vandervoort

LANREOTIDE AUTOGEL 120 MG FOR CHRONIC REFRACTORY DIARRHEA : A MULTICENTER PROSPECTIVE TRIAL.

Raf Bisschops, Vincent De Ruyter, Gauthier Demolin, Didier Baert, Tom Moreels, Piet Pattyn, Hans Verhelst, Luc Lepoutre, Joris Arts, Philip Caenepeel, Patrick Ooghe, Pascal Maisonobe, Jan Tack

Item 1 - 3 / 3
1